Cited by 925TGF-β signaling in diseasesImmune cells in cancerChemokine receptors and signaling

The DOI matches its Crossref record; 60 of the 61 references it cites were found in a registry or an index.

Abrogation of TGFβ Signaling in Mammary Carcinomas Recruits Gr-1+CD11b+ Myeloid Cells that Promote Metastasis

Open access

Yang, Li, Huang, Jianhua, Ren, Xiubao, Gorska, Agnieszka E., Chytil, Anna, Aakre, Mary, Carbone, David P., Matrisian, Lynn M., Richmond, Ann, Lin, P. Charles, Moses, Harold L.·2008·Cancer Cell

DOI 10.1016/j.ccr.2007.12.004PMC PMC2245859

Open this paper in CoChat — free account Open PDF

Abstract

Aberrant TGFbeta signaling is common in human cancers and contributes to tumor metastasis. Here, we demonstrate that Gr-1+CD11b+ myeloid cells are recruited into mammary carcinomas with type II TGF beta receptor gene (Tgfbr2) deletion and directly promote tumor metastasis. Gr-1+CD11b+ cells infiltrate into the invasive front of tumor tissues and facilitate tumor cell invasion and metastasis through a process involving metalloproteinase activity. This infiltration of Gr-1+CD11b+ cells also results in increased abundance of TGF beta 1 in tumors with Tgfbr2 deletion. The recruitment of Gr-1+CD11b+ cells into tumors with Tgfbr2 deletion involves two chemokine receptor axes, the SDF-1/CXCR4 and CXCL5/CXCR2 axes. Together, these data indicate that Gr-1+CD11b+ cells contribute to TGFbeta-mediated metastasis through enhancing tumor cell invasion and metastasis.

Integrity signals

Registry

Crossref · 10.1016/j.ccr.2007.12.004

Cites

60 of 60 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Inflammation and cancer
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis
Condeelis, J. S., & Pollard, J. W. (2006) · Cell · doi:10.1016/j.cell.2006.01.007 · Cited by 2,677
Endothelial Progenitor Cells
Urbich, C., & Dimmeler, S. (2004) · Circulation Research · doi:10.1161/01.res.0000137877.89448.78 · Cited by 2,388
Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells
Gabrilovich, D. I., Chen, H. L., Girgis, K. R., Cunningham, H. T., Meny, G. M., Nadaf, S., Kavanaugh, D., & Carbone, D. P. (1996) · Nature Medicine · doi:10.1038/nm1096-1096 · Cited by 1,977
Self-citation
Dependence of Human Stem Cell Engraftment and Repopulation of NOD/SCID Mice on CXCR4
Peled, A., Petit, I., Kollet, O., Magid, M., Ponomaryov, T., Byk, T., Nagler, A., Ben-Hur, H., Many, A., Shultz, L., et al. (1999) · Science · doi:10.1126/science.283.5403.845 · Cited by 1,644
Matrix Metalloproteinases: Biologic Activity and Clinical Implications
Nelson, A. R., Fingleton, B., Rothenberg, M. L., & Matrisian, L. M. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.5.1135 · Cited by 1,565
Self-citation
Increased Production of Immature Myeloid Cells in Cancer Patients: A Mechanism of Immunosuppression in Cancer
Almand, B., Clark, J. I., Nikitina, E., van Beynen, J., English, N. R., Knight, S. C., Carbone, D. P., & Gabrilovich, D. I. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.1.678 · Cited by 1,340
Self-citation
A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development
Burns, J. M., Summers, B. C., Wang, Y., Melikian, A., Berahovich, R., Miao, Z., Penfold, M. E. T., Sunshine, M. J., Littman, D. R., Kuo, C. J., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052144 · Cited by 1,264
CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment
Burger, J. A., & Kipps, T. J. (2005) · Blood · doi:10.1182/blood-2005-08-3182 · Cited by 1,197
Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis
Yang, L., DeBusk, L. M., Fukuda, K., Fingleton, B., Green-Jarvis, B., Shyr, Y., Matrisian, L. M., Carbone, D. P., & Lin, P. C. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.08.031 · Cited by 1,140
Self-citation

Flagged first, then by citations

Show all 61 references

1 of the 61 references couldn’t be matched to a known paper.

Sorted by citations

Items 701–800 of 925

Highlights on mechanisms of drugs targeting MDSCs: providing a novel perspective on cancer treatment
Pan, W., Sun, Q., Wang, Y., Wang, J., Cao, S., & Ren, X. (2015) · Tumor Biology · doi:10.1007/s13277-015-3363-9 · Cited by 10
Self-citation
Reciprocal Signaling between Myeloid Derived Suppressor and Tumor Cells Enhances Cellular Motility and is Mediated by Structural Cues in the Microenvironment
Shukla, V. C., Duarte‐Sanmiguel, S., Panic, A., Senthilvelan, A., Moore, J. T., Bobba, C. M., Benner, B. N., Carson, W. E., Ghadiali, S. N., & Gallego‐Perez, D. (2020) · Advanced Biosystems · doi:10.1002/adbi.202000049 · Cited by 10
Ex vivo/in vitro effects of aspirin and ibuprofen, bulk and nano forms, in peripheral lymphocytes of prostate cancer patients and healthy individuals
Guma, A. S. S., Akhtar, S., Najafzadeh, M., Isreb, M., Baumgartner, A., & Anderson, D. C. (2020) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2020.503306 · Cited by 10
Resistance to Immune Checkpoint Blockade in Uterine Leiomyosarcoma: What Can We Learn from Other Cancer Types?
Wispelaere, W. D., Annibali, D., Tuyaerts, S., Lambrechts, D., & Amant, F. C. (2021) · Cancers · doi:10.3390/cancers13092040 · Cited by 10
Depletion of phagocytic myeloid cells triggers spontaneous T cell- and NK cell-dependent antitumor activity
Guth, A., Hafeman, S., & DOW, S. W. (2012) · OncoImmunology · doi:10.4161/onci.21317 · Cited by 10
Glycosaminoglycan mimicry by COAM reduces melanoma growth through chemokine induction and function
Piccard, H., Berghmans, N., Korpos, É., Dillen, C., Aelst, I. V., Li, S., Martens, E., Liekens, S., Noppen, S., Damme, J. V., et al. (2011) · International Journal of Cancer · doi:10.1002/ijc.26465 · Cited by 10
Hematopoietic Stem and Progenitor Cell Migration After Hypofractionated Radiation Therapy in a Murine Model
Kane, J. L., Krueger, S. A., Dilworth, J. T., Torma, J., Wilson, G. D., Marples, B., & Madlambayan, G. J. (2013) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2013.08.044 · Cited by 9
Neem leaf glycoprotein salvages T cell functions from Myeloid-derived suppressor cells-suppression by altering IL-10/STAT3 axis in melanoma tumor microenvironment
Sarkar, M., Bhuniya, A., Ghosh, S., Sarkar, A., Saha, A., Dasgupta, S., Bera, S., Chakravarti, M., Dhar, S., Guha, I., et al. (2021) · Melanoma Research · doi:10.1097/cmr.0000000000000721 · Cited by 9
TGFβ Signaling in Myeloid Cells Promotes Lung and Liver Metastasis Through Different Mechanisms
Stefanescu, C., van Gogh, M., Roblek, M., Heikenwälder, M. F., & Borsig, L. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.765151 · Cited by 10
A new approach to overcoming resistance to immunotherapy: nanotechnology
Shao, J., Jin, Y. H., & Jin, C. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1210245 · Cited by 10
Immunomodulatory Effects of TGF-β Family Signaling within Intestinal Epithelial Cells and Carcinomas
Smith, P. M., Means, A. L., & Beauchamp, R. D. (2019) · Gastrointestinal Disorders · doi:10.3390/gidisord1020024 · Cited by 8
Altered Calcium Influx Pathways in Cancer-Associated Fibroblasts
Sadras, F., Stewart, T. A., Robitaille, M., Peters, A. A., Croft, P. K., Soon, P., Saunus, J. M., Lakhani, S. R., Roberts‐Thomson, S. J., & Monteith, G. R. (2021) · Biomedicines · doi:10.3390/biomedicines9060680 · Cited by 9
Pan-Cancer Analysis of the N6-Methyladenosine Eraser FTO as a Potential Prognostic and Immunological Biomarker
Zhao, C., Liu, Y., Ju, S., & Wang, X. (2021) · International Journal of General Medicine · doi:10.2147/ijgm.s331752 · Cited by 9
Mammalian tumor-like organs. 1. The role of tumor-like normal organs and atypical tumor organs in the evolution of development (carcino-evo-devo)
Kozlov, A. P. (2022) · Infectious Agents and Cancer · doi:10.1186/s13027-021-00412-0 · Cited by 9
What Are the Roles of Proprotein Convertases in the Immune Escape of Tumors?
Mehranzadeh, E., Crende, O., Badiola, I., & García-Gallastegui, P. (2022) · Biomedicines · doi:10.3390/biomedicines10123292 · Cited by 9
TGF-β1 precursor and CD8 are potential prognostic and predictive markers in operated breast cancer
Yu, H.-M., Yang, J., Jiao, S., Wang, J., & Li, Y. (2014) · Journal of Huazhong University of Science and Technology [Medical Sciences] · doi:10.1007/s11596-014-1231-2 · Cited by 9
Dichloroacetate modulates cytokines toward T helper 1 function via induction of the interleukin-12–interferon-γ pathway
Matalka, K. Z., Badr, M., Qinna, N. A., & Qadan, F. (2014) · OncoTargets and Therapy · doi:10.2147/ott.s56688 · Cited by 9
Pathological Bases for a Robust Application of Cancer Molecular Classification
Díaz‐Cano, S. J. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms16048655 · Cited by 9
Bone Marrow-Derived Cells in GBM Neovascularization
Bergers, G. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-553-8_31 · Cited by 10
PERK-Phosphorylated eIF2α Pathway Suppresses Tumor Metastasis Through Downregulating Expression of Programmed Death Ligand 1 and CXCL5 in Triple-Negative Breast Cancer
Zou, W., Bai, Y., Wang, X., Cheng, K., Sun, H., Zhang, G., Wang, X., & Yang, Z. (2017) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2017.2237 · Cited by 9
Integrative diagnosis of cancer by combining CTCs and associated peripheral blood cells in liquid biopsy
Zhang, W.-W., Rong, Y., Liu, Q., Luo, C.-L., Zhang, Y., & Wang, F. (2018) · Clinical & Translational Oncology · doi:10.1007/s12094-018-02004-8 · Cited by 10
3D Bone Morphology Alters Gene Expression, Motility, and Drug Responses in Bone Metastatic Tumor Cells
Dadwal, U. C., Merkel, A. R., Page, J. M., Kwakwa, K. A., Kessler, M., & Rhoades, J. A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186913 · Cited by 9
Recurrent and Metastatic Head and Neck Cancer: Mechanisms of Treatment Failure, Treatment Paradigms, and New Horizons
Barham, W. T., Stagg, M. P., Mualla, R., Dileo, M. D., & Kansara, S. (2025) · Cancers · doi:10.3390/cancers17010144 · Cited by 8
Emerging drug targets for triple-negative breast cancer: a guided tour of the preclinical landscape
Xie, X., Lee, J., Iwase, T., Kai, M., & Ueno, N. T. (2022) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2022.2077188 · Cited by 8
Inflammatory and Innate Immune Cells in Cancer Microenvironment and Progression
Brennecke, P., Allavena, P., Laface, I., Mantovani, A., & Bottazzi, B. (2014) · Springer eBooks · doi:10.1007/978-3-662-44006-3_2 · Cited by 8
Transgenic Expression of Polyomavirus Middle T Antigen in the Mouse Prostate Gives Rise to Carcinoma
Lee, S., Jia, S., Zhu, Y., Utermark, T., Signoretti, S., Loda, M. F., Schaffhausen, B. S., & Roberts, T. M. (2011) · Journal of Virology · doi:10.1128/jvi.02609-10 · Cited by 8
Properties of Immature Myeloid Progenitors with Nitric-Oxide-Dependent Immunosuppressive Activity Isolated from Bone Marrow of Tumor-Free Mice
Forghani, P., Harris, W. B., Giver, C. R., Mirshafiey, A., Galipeau, J., & Waller, E. K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064837 · Cited by 8
Recruitment of CD11b+Ly6C+ monocytes in non-small cell lung cancer xenografts challenged by anti-VEGF antibody
Chen, X., Sun, J., Zhang, L.-P., Liao, X., & Liao, R.-X. (2017) · Oncology Letters · doi:10.3892/ol.2017.6236 · Cited by 8
Reversal of postoperative breast cancer metastasis by the use of embedded hydrogel
Yu, Z. (2024) · American Journal of Translational Research · doi:10.62347/vzaw2270 · Cited by 7
Nebulized Inhalation of Engineered Extracellular Vesicles to Destruct Pre-metastatic Niche and Inhibit Postoperative Lung Metastasis in a Mouse Model
Wang, X., Han, X., Yuan, H., Zhang, X., Kang, Y., Wang, Y., Song, P., Su, X., Chen, Z., Liang, H., et al. (2025) · ACS Nano · doi:10.1021/acsnano.5c12218 · Cited by 8
Pharmacological strategies to overcome immune checkpoint inhibitor resistance in non-small cell lung cancer
Xu, Y., Shen, H., Shang, D., & Zhu, C. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2025.1665239 · Cited by 10
Natural lung-tropic TH9 cells: a sharp weapon for established lung metastases
Chen, T., Qiao, C., Yinwang, E., Wang, S., Wen, X., Feng, Y., Jin, X., Li, S.-M., Xue, Y., Zhou, H., et al. (2024) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2024-009629 · Cited by 7
The potential of targeted antiangiogenesis therapies in the treatment of esophageal cancer
Cheung, A. L. M., Xu, W. W., & Li, B. (2015) · Gastrointestinal Cancer Targets and Therapy · doi:10.2147/gictt.s49313 · Cited by 7
Carcinoma cells that have undergone an epithelial-mesenchymal transition differentiate into endothelial cells and contribute to tumor growth
Sphyris, N., King, C., Hoar, J., Werden, S. J., Vijay, G. V., Miura, N., Gaharwar, A. K., & Sarkar, T. R. (2021) · Oncotarget · doi:10.18632/oncotarget.27940 · Cited by 7
Setting up clinical trials for success: Applying preclinical advances in combined TGFβ/PD‐L1 inhibition to ongoing clinical studies
Strait, A. A., & Wang, X. (2021) · Molecular Carcinogenesis · doi:10.1002/mc.23373 · Cited by 7
Induction of arginase-1 in MDSC requires exposure to CD3/CD28 activated T cells
Abdelaal, A. M., Bian, Z., Culpepper, C. D., & Liu, Y. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.198.supp.154.13 · Cited by 7
Influencing factors and solution strategies of chimeric antigen receptor T-cell therapy (CAR–T) cell immunotherapy
Wang, Z., ZHOU, L., & WU, X. (2024) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.32604/or.2024.048564 · Cited by 6
Selective anti-CXCR2 receptor blockade by AZD5069 inhibits CXCL8-mediated pro-tumorigenic activity in human thyroid cancer cells in vitro
Coperchini, F., Greco, A., Petrosino, E., Croce, L., Teliti, M., Marchesi, N., Pascale, A., Calì, B., Pignatti, P., Magri, F., et al. (2024) · Journal of Endocrinological Investigation · doi:10.1007/s40618-024-02410-6 · Cited by 6
Qingrehuoxue formula enhances anti-PD-1 immunotherapy in NSCLC by remodeling the tumor immune microenvironment via TREM2 signaling
Li, B., Jiang, Y.-Y., Li, X., Yu, M., Meng, Q., Wang, D., Zang, J.-M., & Xu, F. (2025) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-025-05020-8 · Cited by 6
Engineered Nanomaterials for Tumor Immune Microenvironment Modulation in Cancer Immunotherapy
Xing, H., & Li, X. (2024) · Chemistry - A European Journal · doi:10.1002/chem.202400425 · Cited by 6
Myeloid Derived Suppressor Cells: Subsets, Expansion, and Role in Cancer Progression
Abastado, J., & Zhi, L. (2012) · InTech eBooks · doi:10.5772/36409 · Cited by 6
Role of TGF-β signaling in EMT, cancer progression and metastasis
Savary, K., & Moustakas, A. (2011) · Drug Discovery Today Disease Models · doi:10.1016/j.ddmod.2011.07.009 · Cited by 6
Myeloid-derived suppressor cells anticipate sustained treatment response in newly-diagnosed and persistent primary immune thrombocytopenia
El-Saied, D. G., Noreldin, N. M., Saad, M. A., Elkhatteb, M. A., & Esheba, N. E. S. (2020) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2020.102529 · Cited by 6
Bone niche and bone metastases
Han, Y., & Kang, Y. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821666-8.00041-4 · Cited by 6
Pseudolycorine chloride ameliorates Th17 cell-mediated central nervous system autoimmunity by restraining myeloid-derived suppressor cell expansion
Zhang, G., Zhu, X., Yang, F., Li, J., Leng, X., Mo, C., Li, L., & Wang, Y. (2022) · Pharmaceutical Biology · doi:10.1080/13880209.2022.2063344 · Cited by 6
Effect of early endometriosis on ovarian reserve and reproductive outcome
Kitaya, K. (2011) · Frontiers in Bioscience-Scholar · doi:10.2741/423 · Cited by 6
Transforming Growth Factor-Beta1 and Myeloid-Derived Suppressor Cells Interplay in Cancer
Santibanez, J. F., & Bjelica, S. (2017) · The Open Cancer Immunology Journal · doi:10.2174/1876401001706010001 · Cited by 6
Chemotherapeutic targeting of the TGF-β pathway in breast cancers
Lee, Y., & Schiemann, W. P. (2013) · Breast Cancer Management · doi:10.2217/bmt.13.74 · Cited by 6
CXCR4/CXCL12 blockade therapy; a new horizon in TNBC therapy
Khaleel, A. Q., Altalbawy, F. M. A., Jabir, M. S., F.Hasan, T., Jain, V. D., Abbot, V., Nakash, P., Kumar, M., Mustafa, Y. F., & Jawad, M. A. (2025) · Medical Oncology · doi:10.1007/s12032-025-02705-5 · Cited by 5
Adjuvant conditioning shapes the adaptive immune response promoting immunotolerance via NLRP3/interleukin-1
Boccia, T., Pan, W., Fattori, V., Cervantes‐Díaz, R., Rogers, M. S., Zanoni, I., & Cuenca, A. G. (2025) · iScience · doi:10.1016/j.isci.2025.112653 · Cited by 5
Enhanced Apc adenoma formation after epithelial CUL4B deletion by recruitment of myeloid-derived suppressor cells
Guo, B., Zheng, Y., Fan, Y., Yang, Y., Wang, Y., Qin, L., An, Y., Xu, X., Zhang, X., Sun, G., et al. (2024) · Neoplasia · doi:10.1016/j.neo.2024.101005 · Cited by 5
Role of cytokines in hepatocellular carcinoma
Aghayev, T., Titerina, E. K., Хорева, М. В., & Gankovskaya, L. V. (2022) · Medical Immunology (Russia) · doi:10.15789/1563-0625-roc-2512 · Cited by 6
Effective suppression of tumor growth and hepatic metastasis of neuroblastoma by NKT-stimulatory phenyl glycolipid
Wu, T.-N., Hung, J., Hung, T., Wang, Y., Wu, J., & Yu, A. L.-T. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117040 · Cited by 5
Multifaceted role of myeloid-derived suppressor cells in colorectal cancer
Zhang, J., Lian, J., Li, N., Yueying, & Wu, G. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.115274 · Cited by 6
Gr-1+CD11b+ Immature Myeloid Cells (IMC) Promote Resistance of Pro-Inflammatory T Cells to Suppression by Regulatory T Cells in Atherosclerotic Apo E- Deficient Mice
Chen, Y.-L., Jian, Y., Liu, M., Zhong, L., Zhang, F., Yang, W., Xu, Z., Chen, G., & Liu, Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108620 · Cited by 5
Tumor-induced Myeloid-derived Suppressor Cells
Ostrand‐Rosenberg, S., Sinha, P., Beury, D. W., Chornoguz, O., & Parker, K. H. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-394296-8.00028-2 · Cited by 5
Molecular links between inflammation and cancer
Allavena, P., Germano, G., & Mantovani, A. (2015) · Cambridge University Press eBooks · doi:10.1017/cbo9780511979811.018 · Cited by 5
Establishment of Prostate Tumor Growth and Metastasis Is Supported by Bone Marrow Cells and Is Mediated by PIP5K1α Lipid Kinase
Karlsson, R. T. G., Larsson, P., Рифкатовна, М. Р., Khaja, A. S. S., Sarwar, M., Semenas, J., Chen, S., Hedblom, A., Wang, T., Ekström‐Holka, K., et al. (2020) · Cancers · doi:10.3390/cancers12092719 · Cited by 5
Landscape of Immunotherapy in Genitourinary Malignancies
Ravindranathan, D., Alhalabi, O., Rafei, H., Shah, A. Y., & Bilen, M. A. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-79308-1_5 · Cited by 6
Lung Metastases
Hayman, J., Naidoo, J., & Ettinger, D. S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-47674-4.00057-8 · Cited by 6
Multistage Carcinogenesis: Cell and Animal Models
Kulesz-Martin, M. F., Ouyang, X., Barling, A. N., Gallegos, J. R., Liu, Y., & Medler, T. R. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.02218-2 · Cited by 5
TGF-β signaling in organoids: The mechanisms and applications in 3D
Zhu, S., Liu, J., Qiu, X., Cai, G., & Gao, M. (2025) · Cell organoid (Print) · doi:10.26599/co.2025.9410015 · Cited by 4
TGF-β helps cells fly solo
Matise, L. A., Pickup, M. W., & Moses, H. L. (2009) · Nature Cell Biology · doi:10.1038/ncb1109-1281 · Cited by 4
Self-citation
Mobilizing and evaluating anticancer T cells: pitfalls and solutions
Robert-Tissot, C., Nguyen, L. T., Ohashi, P. S., & Speiser, D. E. (2013) · Expert Review of Vaccines · doi:10.1586/14760584.2013.843456 · Cited by 4
Recent Developments in the Study of the Microenvironment of Cancer and Drug Delivery
Chaudhary, B., Kumar, P., Arya, P., Singla, D., Kumar, V., Kumar, D., Roshan, S., Wadhwa, S., Gulati, M., Singh, S. K., et al. (2022) · Current Drug Metabolism · doi:10.2174/1389200224666230110145513 · Cited by 4
Tumor-mediated immunosuppression and cytokine spreading affects the relation between EMT and PD-L1 status
Lems, C. M., Burger, G. A., & Beltman, J. B. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1219669 · Cited by 4
Hematopoietic Derived Cell Infiltration of the Intestinal Tumor Microenvironment inApcMin/+Mice
Davis, C., Price, R. L., Acharya, G., Baudino, T. A., Borg, T. K., Berger, F. G., & Peña, M. M. O. (2011) · Microscopy and Microanalysis · doi:10.1017/s1431927611000043 · Cited by 4
Myeloid-Derived Suppressor Cells in Some Oncohematological Diseases
Ponomarev, А. V. (2017) · Clinical oncohematology · doi:10.21320/2500-2139-2017-10-1-29-38 · Cited by 4
Inflammation and cancer
Mackenzie, G. G. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823397-9.00003-x · Cited by 4
Nanotechnology and Immunomodulators in Cancer
Volovat, C. D., Volovăț, S. R., & Agop, M. (2022) · Springer eBooks · doi:10.1007/978-981-16-6379-6_5 · Cited by 4
Immune Cells Within the Tumor Microenvironment
Spano, D., & Zollo, M. (2013) · Springer eBooks · doi:10.1007/978-3-7091-1300-4_1 · Cited by 4
Immune Suppressive Myeloid-Derived Suppressor Cells in Cancer
Ostrand‐Rosenberg, S. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-374279-7.17015-8 · Cited by 4
Regulation of CXC chemokine receptor function through intracellular trafficking and novel receptor-interacting proteins.
Neel, N. F. (2008) · Europe PMC (PubMed Central) · Cited by 4
IL-4 receptor targeting as an effective immunotherapy against triple-negative breast cancerPreprint
Parveen, S., Siddharth, S., Cheung, L. S., Kumar, A., Murphy, J. R., Sharma, D., & Bishai, W. R. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.08.05.238824 · Cited by 4
Regulatory Role of Transforming Growth Factor-β Signals in the Migration and Tumor Formation of HOC313-LM cells, an Oral Squamous Cell Carcinoma
Takahashi, K., Podyma‐Inoue, K. A., Takao, C., Yoshimatsu, Y., Muramatsu, T., Inazawa, J., & Watabe, T. (2018) · THE JOURNAL OF THE STOMATOLOGICAL SOCIETY JAPAN · doi:10.5357/koubyou.85.2_52 · Cited by 3
TGF-β as Tumor Suppressor: Lessons from Mouse Models
Valcourt, U., Vincent, D., & Bartholin, L. (2013) · Springer eBooks · doi:10.1007/978-4-431-54409-8_6 · Cited by 3
Preoperative administration of polysaccharide Kureha and reduced plasma transforming growth factor-β in patients with advanced gastric cancer: A randomized clinical trial
Yamashita, K., Sakuramoto, S., Mieno, H., Nemoto, M., Shibata, T., Katada, N., Ohtsuki, S., Sakamoto, Y., Hoshi, K., Wang, G., et al. (2015) · Molecular and Clinical Oncology · doi:10.3892/mco.2015.488 · Cited by 3
Microenvironmental Regulation of Metastasis by Exosomes
Zhang, H., García‐Santos, G., Peinado, H., & Lyden, D. C. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3697-3_9 · Cited by 4
Dissecting neutrophil complexity in cancer
Ponzetta, A., Mantovani, A., & Jaillon, S. (2017) · Emerging Topics in Life Sciences · doi:10.1042/etls20170062 · Cited by 3
Tumor-Induced Myeloid-Derived Suppressor Cells
Sanctis, F. D., Bronte, V., & Ugel, S. (2017) · ASM Press eBooks · doi:10.1128/9781555819194.ch49 · Cited by 3
Progesterone treatment enhances the expansion of placental immature myeloid cells in a mouse model of premature labor
Gutzeit, O., Segal, L., Hertz, R., Burke, Y. Z., Paz, G., Hantisteanu, S., Ginsberg, Y., Hallak, M., Pencovich, N., Beloosesky, R., et al. (2018) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2018.10.003 · Cited by 3
Current Landscape of Immunotherapy in Genitourinary Malignancies
Alhalabi, O., Rafei, H., Bilen, M. A., & Shah, A. Y. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-41008-7_6 · Cited by 3
Notch Signaling Mediates Tumor-CAF Crosstalk in Basal-like Breast Cancer
Song, J. (2014) · TSpace (University of Toronto) · Cited by 3
Parallels in Canonical Developmental Signaling Pathways between Normal Development and the Tumor MicroenvironmentPreprint
Segal, J. E., Cronk, J. C., Ball, B., Forbes, G. E., Jackett, K. N., Li, K. P., Osorno, A. M., Montalvan, E. S. A., Browne, A., Lake, J. A., et al. (2025) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041609 · Cited by 3
Immune Niche Formation in Engineered Mouse Models Reveals Mechanisms of Tumor DormancyPreprint
Ahad, A., Leng, F., Ichise, H., Schrom, E. C., So, J. Y., Sellner, C., Gu, Y., Wang, W., Do, K. C., Park, W. Y., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.16.649000 · Cited by 3
Oligomeric cystatin C supports the immunosuppressive activity of myeloid cells through interaction with inhibitory receptors
Zhang, C., He, Y., Liu, X., Xie, J., Fang, M., Yang, X., Huang, R., Lou, Q., Li, B., Gupta, A., et al. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02462-x · Cited by 2
Local gene editing of fibroblasts in tumors reveals a new cancer-associated fibroblast state
Kuhn, N. F., Zaleta-Linares, I., Hu, K. H., Courau, T., Davidson, B. R., Tam, T., Chu, C.-W., Kinet, M., Rosenblum, M. D., Combes, A. J., et al. (2026) · The Journal of Experimental Medicine · doi:10.1084/jem.20251228 · Cited by 5
BCG-trained macrophages promote pan-anti-tumor activity through epigenetic rewiring of NOX2-ROS axis
Sun, R.-M., Yang, Y., Lai, Y., Wang, H., Yang, X.-X., Ji, P., Chen, Y.-Y., Liu, Z.-Y., Ginhoux, F., Fan, X.-Y., et al. (2026) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-026-03708-4 · Cited by 2
Therapeutically Targeting Epigenetic Regulation of Cancer Stem Cells
Ffrench, B., O’Leary, J. J., & Gallagher, M. F. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800206-3.00027-6 · Cited by 2
Rat prostate tumors induce DNA synthesis in remote organs
Bergström, S. H., Lundholm, M., Nordstrand, A., & Bergh, A. R. J. (2022) · Scientific Reports · doi:10.1038/s41598-022-12131-6 · Cited by 2
The asymmetric effects of exchange rate volatility on UK–Pakistan trade flows: New evidence from nonlinear ARDL approach
Jabeen, S. (2024) · Journal of International Trade & Economic Development · doi:10.1080/09638199.2024.2379572 · Cited by 2
Mechanism of Tumor Growth and Metastasis
Dias, F. C. R., Oliveira, J. B., Pinheiro, B. S. S., Pacheco, H. F. M., Rodrigues, J. G., Fernandes, J. L. F., & Gomes, M. D. L. M. (2024) · Interdisciplinary cancer research · doi:10.1007/16833_2024_406 · Cited by 2
Tumor Inflammatory Microenvironment in EMT and Metastasis
Yuan, T., Wu, Y., & Zhou, B. P. (2012) · InTech eBooks · doi:10.5772/32219 · Cited by 2
Myeloid Suppressor Cells Regulate the Lung Environment—Response
Yan, H. H., Pickup, M. W., Pang, Y., Gorska, A. E., Li, Z., Chytil, A. M., Geng, Y., Gray, J. W., Moses, H. L., & Li, Y. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0688 · Cited by 2
Self-citation
The Role of Bone Marrow-Derived Progenitor Cells in Tumor Growth and Angiogenesis
Dudley, A. C., Cloer, E. W., & Melero‐Martin, J. M. (2012) · Stem cells and cancer stem cells · doi:10.1007/978-94-007-4798-2_5 · Cited by 2
Macrophage Differentiation and Activation States in the Tumor Microenvironment
Ginderachter, J. A. V. (2013) · Springer eBooks · doi:10.1007/978-94-007-6217-6_17 · Cited by 1
Disparate functions of myeloid-derived suppressor cells in cancer metastasis
Edgington‐Mitchell, L. E., & Parker, B. S. (2014) · Cancer Forum · Cited by 2
Cancer Immunotherapy
Guth, A., & DOW, S. W. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-2362-5.00013-x · Cited by 3
Multistage Carcinogenesis: Cell and Animal Models
Kulesz-Martin, M. F., Gallegos, J. R., & Liu, Y. (2010) · Elsevier eBooks · doi:10.1016/b978-0-08-046884-6.01402-0 · Cited by 2
Relación estructura/actividad de proantocianidinas procedentes de fuentes naturales de origen vegetal
Mateos‐Martín, M. L. (2013) · DIGITAL.CSIC (Spanish National Research Council (CSIC)) · doi:10.13039/501100004837

Authors: Yang, L., Huang, J., Ren, X., Gorska, A. E., Chytil, A., Aakre, M., Carbone, D. P., Matrisian, L. M., Richmond, A., Lin, P. C., & Moses, H. L.
Affiliations: Vanderbilt University (US)
Corresponding author: Moses, Harold L.
ORCID: Huang, Jianhua
Ren, Xiubao
Gorska, Agnieszka E.
Carbone, David P.
Matrisian, Lynn M.
Richmond, Ann
Moses, Harold L.
Venue: Cancer Cell
Publisher: Elsevier BV
Published: 2008-01
Volume: 13
Issue: 1
Pages: 23-35
ISSN: 1535-6108 (ISSN-L)
DOI: 10.1016/j.ccr.2007.12.004
PMC: PMC2245859
OpenAlex: W2130870648
Cited by: 918
References: 61
Citations by year: 2026: 10 · 2025: 19 · 2024: 30 · 2023: 25 · 2022: 41 · 2021: 58 · 2020: 41 · 2019: 52 · 2018: 42 · 2017: 47 · 2016: 62 · 2015: 59 · 2014: 64 · 2013: 78 · 2012: 77
FWCI: 29.18
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 2024 d)
Locations: Cancer Cell (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Funders: U.S. Department of Veterans Affairs (IK6 BX005225)
Vanderbilt University
National Cancer Institute (CA068485, CA 085492, R01CA085492, R01CA116021, CA102162, R01CA108856, CA126505, R01CA076321, R01CA034590, P50CA098131, R01CA102162, CA108856, P30CA068485, U54CA126505)
National Institute of Diabetes and Digestive and Kidney Diseases (P30 DK58404, P30DK058404)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
Keywords: TGF-beta signaling, breast cancer, tumor-associated macrophages, metastasis, tumor invasion, metalloproteinase activity, SDF-1/CXCR4 axis, chemokine receptors, myeloid cell recruitment
MeSH terms: Receptor, Transforming Growth Factor-beta Type II, Animals, Breast Neoplasms, Female, Humans, Models, Biological, Neoplasm Invasiveness, Neoplasm Metastasis, Signal Transduction, Transforming Growth Factor beta, Protein Serine-Threonine Kinases, Gene Deletion, Receptors, Transforming Growth Factor beta, Matrix Metalloproteinases, Myeloid Cells, CD11b Antigen, Cell Line, Tumor, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Abrogation of TGFβ Signaling in Mammary Carcinomas Recruits Gr-1+CD11b+ Myeloid Cells that Promote Metastasis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks